Tonix Pharmaceuticals (NASDAQ: TNXP) , a biopharmaceutical company with marketed products and a robust development pipeline, announced that the FDA w ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results